Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Working Capital Changes (2020 - 2025)

HCW Biologics (HCWB) has disclosed Other Working Capital Changes for 6 consecutive years, with -$257894.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Working Capital Changes changed N/A year-over-year to -$257894.0, compared with a TTM value of -$775081.0 through Sep 2025, down 22.2%, and an annual FY2024 reading of -$831622.0, down 154.52% over the prior year.
  • Other Working Capital Changes was -$257894.0 for Q2 2025 at HCW Biologics, down from $257894.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.3 million in Q2 2022 and bottomed at -$1.4 million in Q1 2022.
  • Average Other Working Capital Changes over 5 years is -$91900.7, with a median of -$47838.5 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes soared 784.35% in 2022, then crashed 1376.26% in 2023.
  • Year by year, Other Working Capital Changes stood at $150356.0 in 2021, then tumbled by 126.03% to -$39136.0 in 2022, then plummeted by 1376.26% to -$577750.0 in 2023, then tumbled by 34.16% to -$775081.0 in 2024, then skyrocketed by 66.73% to -$257894.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for HCWB at -$257894.0 in Q2 2025, $257894.0 in Q1 2025, and -$775081.0 in Q4 2024.